Irreversible severe kidney injury and anuria in a 3‐month‐old girl with atypical haemolytic uraemic syndrome under administration of eculizumab

Yusuke Okuda(Kitasato University), Masataka Honda(Rikkyo University), Kenji Ishikura(Kitasato University), Chikako Terano(Tokyo Metropolitan Children's Medical Center), Kentaro Ogata(National Defense Medical College), Riku Hamada, Ryoko Harada(Tokyo Metropolitan Children's Medical Center), Hiroshi Hataya(Japanese Society for Dialysis Therapy)

Nephrology

January 28, 2016

10.1111/nep.12582

Cited by 5

Related Papers

Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

|The Lancet|2014|450

IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome

|Pediatric Nephrology|2022|278

Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease

|Clinical and Experimental Nephrology|2013|267

Epidemiology of pediatric chronic kidney disease/kidney failure: learning from registries and cohort studies

|Pediatric Nephrology|2021|149

A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment

|Kidney International|2014|135